![]() |
市場調查報告書
商品編碼
2128231
醫療物流市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。Healthcare Logistics Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球醫療物流市場預計到2025年將達到1,025.4億美元,從2026年的1,076.2億美元成長到2034年的1,635.9億美元,預測期內複合年成長率(CAGR)為5.4%。北美地區在醫療物流市場中佔領先地位,預計到2025年將佔37.28%的市場佔有率,這得益於其先進的醫療基礎設施、強大的藥品生產能力以及溫控物流解決方案的廣泛主導。
醫療物流涵蓋藥品、醫療設備、疫苗、生物製藥、實驗室檢體和臨床試驗材料的安全運輸、倉儲、庫存管理和配送。臨床試驗活動的活性化、對特種藥品需求的成長、藥品外包的擴張、直接送藥服務的擴展,正在加速全球市場的成長。此外,對冷鏈基礎設施和數位化供應鏈技術的投資正在提高整個醫療物流網路的營運效率。
醫療保健物流市場趨勢
影響醫療物流市場的關鍵趨勢之一是即時溫度監控技術的日益普及。製藥企業和物流供應商正擴大部署物聯網感測器、GPS追蹤、RFID設備、雲端監控平台和自動化警報系統,以確保產品在運輸和儲存的整個過程中的品質。
生物製藥、疫苗、細胞和基因療法以及其他對溫度敏感的藥物的需求不斷成長,推動了對先進冷鏈物流的需求。這些技術能夠持續監測溫度、濕度、路線偏差和運輸條件,從而減少產品損失並確保符合監管標準。
市場促進因素
全球臨床試驗數量的不斷成長是推動醫療物流需求的主要因素。製藥、生物技術和醫療設備公司需要專業的物流服務,以便在多個國家運輸臨床試驗材料、生物檢體、臨床實驗藥物和實驗室設備。
對醫藥研發投入的增加,以及外包活動的擴張,正在催生對倉儲、配送和溫控運輸服務的強勁需求。藥品生產和特藥生產的持續成長,進一步推動了市場的長期成長。
市場限制因素
冷鏈基礎設施的高成本仍然是醫療物流供應商面臨的最大挑戰之一。維護經過認證的冷藏倉庫、專用運輸車輛、緊急電源系統、監控設備以及遵守相關法規都需要大量資金,從而大幅增加營運成本。
高昂的基礎設施成本對中小型物流公司構成了准入壁壘,同時也導致製藥企業和醫療保健提供者的整個供應鏈成本增加。
市場機遇
醫藥冷鍊網路的快速擴張為市場參與企業帶來了巨大的機會。對疫苗、生物製藥、胰島素、癌症治療藥物和先進生物製藥的需求不斷成長,正在推動對專用冷藏運輸、經過驗證的儲存設施和智慧包裝技術的投資。
新興經濟體醫療保健支出不斷成長和藥品出口不斷擴大,為醫療保健物流公司創造了更多新的成長機會。
市場挑戰
部分開發中國家醫療基礎設施匱乏,臨床試驗數量相對較少,這些因素持續限制市場擴張。此外,薄弱的交通網路、冷鏈設施不足、物流服務供應商數量有限以及醫藥生態系統不發達,也降低了這些地區對先進醫療物流服務的需求。
市場區隔
根據服務類型,市場細分為運輸服務、倉儲服務、配送服務和其他服務。 2025年,運輸服務的成長主要受藥品運輸量、診斷試劑和樣本運輸量增加的推動。預計配送服務將持續穩定成長。
依產品類型分類,市場可分為藥品、醫療設備、臨床試驗材料和其他。預計到2025年,藥品將佔最大的市場佔有率,達到46.7%,這主要得益於藥品產量、生物製藥生產和臨床研究活動的成長。
根據溫度控制方式,市場可分為冷鏈物流與非冷鏈物流。預計到2025年,由於大量學名藥需要常溫儲存,非冷鏈物流將佔最大市場佔有率,但預計在預測期內,冷鏈物流的成長速度將更快。
就物流模式而言,市場可分為自營服務和外包服務。到2025年,隨著製藥公司越來越依賴第三方物流供應商以降低基礎設施成本並利用專業的冷鏈能力,外包服務將佔市場主導地位。
按最終用戶分類,市場包括製藥和生物技術公司、醫療設備製造商、醫院和診所等。由於藥品生產和疫苗生產的擴張以及臨床研究活動的增加,製藥和生物技術公司仍然是主要的最終用戶群體。
由於強大的藥品生產能力、先進的醫療基礎設施和大量的臨床試驗,預計到2025年,北美市場規模將保持在382.3億美元,繼續保持全球最大區域市場的地位。在北美地區,美國仍將是最大的各國市場。
在歐洲,由於藥品分銷活動的增加、庫存管理系統的加強以及醫療保健供應鏈的擴張,預計市場將保持穩定成長。德國和英國仍然是該地區成長的主要驅動力。
亞太地區正在崛起成為成長最快的市場之一,這主要得益於中國、印度和日本不斷擴大的製藥業、不斷改善的醫療保健基礎設施、更嚴格的監管合規性以及對溫控物流投資的增加。
在拉丁美洲、中東和非洲,隨著醫療保健產業、藥品分銷網路和冷鏈能力的投資在全部區域不斷改善,預計將實現溫和成長。
The global healthcare logistics market was valued at USD 102.54 billion in 2025 and is projected to grow from USD 107.62 billion in 2026 to USD 163.59 billion by 2034, registering a CAGR of 5.4% during the forecast period. North America dominated the healthcare logistics market with a 37.28% market share in 2025, driven by advanced healthcare infrastructure, strong pharmaceutical manufacturing, and widespread adoption of temperature-controlled logistics solutions.
Healthcare logistics involves the secure transportation, warehousing, inventory management, and distribution of pharmaceuticals, medical devices, vaccines, biologics, laboratory samples, and clinical trial materials. Rising clinical trial activity, increasing demand for specialty medicines, growing pharmaceutical outsourcing, and the expansion of direct-to-patient delivery services are accelerating market growth worldwide. Moreover, investments in cold-chain infrastructure and digital supply chain technologies are improving operational efficiency across healthcare logistics networks.
Healthcare Logistics Market Trends
One of the major trends shaping the healthcare logistics market is the increasing adoption of real-time temperature monitoring technologies. Pharmaceutical manufacturers and logistics providers are increasingly deploying IoT-enabled sensors, GPS tracking, RFID devices, cloud-based monitoring platforms, and automated alerts to ensure product integrity throughout transportation and storage.
The growing demand for biologics, vaccines, cell and gene therapies, and other temperature-sensitive medicines has increased the need for advanced cold-chain logistics. These technologies provide continuous visibility into temperature, humidity, route deviations, and shipment conditions, reducing product losses and ensuring compliance with regulatory standards.
Market Drivers
The growing number of clinical trials worldwide is a major factor driving healthcare logistics demand. Pharmaceutical, biotechnology, and medical device companies require specialized logistics services for transporting clinical trial materials, biological samples, investigational drugs, and laboratory equipment across multiple countries.
Increasing investments in pharmaceutical research and development, coupled with expanding outsourcing activities, are generating strong demand for warehousing, distribution, and temperature-controlled transportation services. The continuous expansion of pharmaceutical manufacturing and specialty medicine production further supports long-term market growth.
Market Restraints
The high cost of cold-chain infrastructure remains one of the biggest challenges for healthcare logistics providers. Maintaining validated refrigerated warehouses, specialized transportation fleets, backup power systems, monitoring equipment, and regulatory compliance significantly increases operational expenses.
These high infrastructure costs create barriers for small and medium-sized logistics companies while increasing overall supply chain costs for pharmaceutical manufacturers and healthcare providers.
Market Opportunities
The rapid expansion of pharmaceutical cold-chain networks presents significant opportunities for market participants. Growing demand for vaccines, biologics, insulin, oncology therapies, and advanced biologic medicines is encouraging investments in specialized refrigerated transportation, validated storage facilities, and smart packaging technologies.
Increasing healthcare expenditure across emerging economies and expanding pharmaceutical exports are further creating new growth opportunities for healthcare logistics providers.
Market Challenges
Limited healthcare infrastructure and a relatively low number of clinical trials in several developing countries continue to restrict market expansion. Weak transportation networks, insufficient cold-chain facilities, limited logistics service providers, and underdeveloped pharmaceutical ecosystems reduce demand for advanced healthcare logistics services in these regions.
Market Segmentation
Based on service type, the market is segmented into transportation services, warehousing & storage services, distribution services, and others. Transportation services dominated the market in 2025 due to rising pharmaceutical shipments, diagnostic testing volumes, and increasing movement of laboratory samples. Distribution services are expected to witness steady future growth.
By product type, the market includes pharmaceutical products, medical devices, clinical trial materials, and others. Pharmaceutical products accounted for the largest market share of 46.7% in 2025, supported by increasing drug production, biologics manufacturing, and clinical research activities.
Based on temperature control, the market is categorized into cold-chain logistics and non-cold-chain logistics. Non-cold-chain logistics held the largest share in 2025 due to the high volume of generic medicines requiring ambient storage, while cold-chain logistics is projected to experience faster growth during the forecast period.
By logistics model, the market is divided into in-house and outsourced services. The outsourced segment dominated in 2025 as pharmaceutical companies increasingly relied on third-party logistics providers to reduce infrastructure costs and access specialized cold-chain capabilities.
Based on end user, the market comprises pharmaceutical & biotechnology companies, medical device companies, hospitals & clinics, and others. Pharmaceutical and biotechnology companies remained the leading end-user segment owing to expanding drug manufacturing, vaccine production, and increasing clinical research activities.
North America remained the largest regional market with a value of USD 38.23 billion in 2025, supported by robust pharmaceutical production, advanced healthcare infrastructure, and a high volume of clinical trials. The U.S. continues to represent the largest national market within the region.
Europe is expected to witness stable growth due to increasing pharmaceutical distribution activities, stronger inventory management systems, and expanding healthcare supply chains. Germany and the U.K. remain key contributors to regional growth.
Asia Pacific is emerging as one of the fastest-growing markets owing to expanding pharmaceutical manufacturing, improving healthcare infrastructure, increasing regulatory compliance, and growing investments in temperature-controlled logistics across China, India, and Japan.
Latin America and the Middle East & Africa are projected to record moderate growth as healthcare investments, pharmaceutical distribution networks, and cold-chain capabilities continue to improve across these regions.
Competitive Landscape
The healthcare logistics market remains highly competitive with global logistics providers focusing on expanding cold-chain infrastructure, pharmaceutical warehousing, and specialized healthcare transportation services. Companies are investing in strategic partnerships, acquisitions, and facility expansions to strengthen their market presence.
Major companies operating in the market include DHL Group, United Parcel Service of America (UPS), FedEx, Kuehne+Nagel, DB Schenker, DSV, CEVA Logistics, GEODIS, Cencora Inc., and Marken. These organizations continue expanding temperature-controlled logistics networks and pharmaceutical distribution capabilities to meet the growing global demand.
Key Industry Developments
Conclusion
The global healthcare logistics market is positioned for steady long-term growth, supported by expanding pharmaceutical manufacturing, increasing clinical trials, rising biologics and vaccine distribution, and greater adoption of advanced cold-chain technologies. Continuous investments in temperature-controlled infrastructure, digital tracking systems, and specialized logistics services will strengthen supply chain efficiency while supporting the safe delivery of healthcare products worldwide. With growing healthcare demand across both developed and emerging economies, healthcare logistics providers are expected to play an increasingly critical role in ensuring secure, compliant, and efficient medical supply chains through 2034.
Segmentation By Service Type, Product Type, Temperature Control, Logistics Model, End User, and Region
By Service Type * Transportation Services
By Product Type * Pharmaceutical Products
By Temperature Control * Cold Chain Logistics
By Logistics Model * In-house
By End User * Pharmaceutical & Biotechnological Companies
By Region * North America (By Service Type, By Product Type, By Temperature Control, By Logistics Model, By End User, and by Country)